ousia tirzepatide Compounded GLP-1/GIP (Tirzepatide) Ousia was a disaster. :
Description
Crestan D, Trojniak MP, Francescon S, et al
Eligible RCTs evaluated tirzepatide or GLP-1RAs and reported major adverse cardiovascular events (MACE), CV mortality, all-cause mortality, non-fatal myocardial infarction (MI) or non-fatal stroke
SDV The SDV procedures were closely following prior studies 22,58,106,109
minor injection site reactions or allergic reactions are possible
Acknowledgments GNP is supported by funding from the Canadian Institutes of Health Research (CIHR)
